- Home
- GLO vs OM Comparison
GLO vs OM Comparison
Compare GLO & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLO
- OM
- Stock Information
- Founded
- GLO 2006
- OM 2003
- Country
- GLO United States
- OM United States
- Employees
- GLO N/A
- OM N/A
- Industry
- GLO Finance/Investors Services
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GLO Finance
- OM Health Care
- Exchange
- GLO Nasdaq
- OM Nasdaq
- Market Cap
- GLO 247.6M
- OM 233.1M
- IPO Year
- GLO N/A
- OM 2020
- Fundamental
- Price
- GLO $5.71
- OM $12.06
- Analyst Decision
- GLO
- OM Hold
- Analyst Count
- GLO 0
- OM 1
- Target Price
- GLO N/A
- OM $22.00
- AVG Volume (30 Days)
- GLO 170.5K
- OM 266.2K
- Earning Date
- GLO 01-01-0001
- OM 11-10-2025
- Dividend Yield
- GLO 11.38%
- OM N/A
- EPS Growth
- GLO N/A
- OM N/A
- EPS
- GLO N/A
- OM N/A
- Revenue
- GLO N/A
- OM $119,304,000.00
- Revenue This Year
- GLO N/A
- OM $12.46
- Revenue Next Year
- GLO N/A
- OM $10.51
- P/E Ratio
- GLO N/A
- OM N/A
- Revenue Growth
- GLO N/A
- OM 2.47
- 52 Week Low
- GLO $4.08
- OM $5.85
- 52 Week High
- GLO $5.18
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- GLO 45.98
- OM 38.01
- Support Level
- GLO $5.72
- OM $12.48
- Resistance Level
- GLO $5.88
- OM $13.29
- Average True Range (ATR)
- GLO 0.06
- OM 0.72
- MACD
- GLO -0.01
- OM -0.23
- Stochastic Oscillator
- GLO 28.96
- OM 16.59
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.